OpenEvidence logo

OpenEvidence

Launched during the Mayo Clinic Platform Accelerate program and featured by the New England Journal of Medicine AI, OpenEvidence is the world’s leading medical AI.

Growth Trajectory

OpenEvidence shows growth potential through continuous AI development for improved content delivery, expansion through licensing agreements with third parties, and potential acquisitions of other companies. They also can expand by offering new specialized medical content, data enrichment, and advertising optimization. Their focus on personalized content delivery positions them well for continued expansion within the healthcare information space.

Technical Challenges

Ensuring data security and privacy
Managing AI accuracy and reliability
Preventing inclusion of protected health information (PHI) in user inputs
Maintaining compliance with regulations such as HIPAA and GDPR
Integrating data from various sources and formats

Tech Stack

AILarge language modelsWebsitesMobile applicationsCookiesPixelsTagsWeb beaconsSoftware development kits

Team Size

Healthcare professionals
Medical researchers
Data analytics
Advertising management

Key Risks

Ensuring data security and privacy, especially in compliance with HIPAA and other regulations.
Maintaining the accuracy and reliability of AI-driven content.
Managing information overload in the medical field and delivering relevant results.
Complying with healthcare marketing and advertising regulations.
Talent acquisition challenges in the competitive AI and healthcare technology sectors.

Opportunities

Further development of AI-driven personalization for clinical decision support.
Expanding content offerings and integration of multimedia and clinical findings.
Leveraging partnerships with healthcare providers and pharmaceutical companies.
Expanding licensing agreements with third parties for data use and service delivery.
Capitalizing on the growing need for accessible and unbiased medical information.
Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats